Back to top

Image: Bigstock

Merit Medical Systems, Inc.

Read MoreHide Full Article

Merit Medical outperformed the industry in a year’s time. Solid growth in the Cardiovascular segment is a positive along with expansion in gross margin. Solid international growth buoys optimism. Management is optimistic about the alliance with NinePoint Medical. The recent acquisition of product distribution agreements for the DirectACCESS Medical PTA Balloon Catheter is encouraging as well. The company also became the exclusive worldwide distributor for the Q50 PLUS Stent Graft Balloon. Recently, the company received FDA 510(k) clearance for a series of new tracheal/bronchial mini-stents.  The company also received 510(k) clearance for EmboCube product line. However, surging operating expenses is a concern. Headwinds like stiff competition and higher consolidation in the healthcare industry add to the woes.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Merit Medical Systems, Inc. (MMSI) - free report >>